ReviewExpert review of cardiovascular therapy2010
Cardiovascular disease risk reduction with sleep apnea treatment.
Review in Expert review of cardiovascular therapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Impact of continuous positive airway pressure therapy on renin-angiotensin-aldosterone system in obstructive sleep apnea: an updated systematic review and meta-analysis.Sleep & breathing = Schlaf & Atmung · 2026Pooled it
- Obstructive sleep apnea syndrome (OSAS) and swallowing function-a systematic review.Sleep & breathing = Schlaf & Atmung · 2020Pooled it
- Comprehensive Management of Obstructive Sleep Apnea With CPAP in a Surgical Otolaryngology Practice.The Laryngoscope · 2025Article
- Linking Sleep Disorders to Atrial Fibrillation: Pathways, Risks, and Treatment Implications.Biology · 2024Review
- Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review.Cureus · 2024Review
- The Impact of Intermittent Hypoxemia on Left Atrial Remodeling in Patients with Obstructive Sleep Apnea Syndrome.Life (Basel, Switzerland) · 2022Article
- Stratifying the Risk of Cardiovascular Disease in Obstructive Sleep Apnea Using Machine Learning.The Laryngoscope · 2022Article
- The Ignored Parameter in the Diagnosis of Obstructive Sleep Apnea Syndrome: The Oxygen Desaturation Index.Turkish archives of otorhinolaryngology · 2018Article
- Sleep disorders in the elderly: Diagnosis and management.Journal of general and family medicine · 2017Review
- Use of Sleep Medications and Mortality: The Hordaland Health Study.Drugs - real world outcomes · 2015Article
- Trauma and syncope-evidence for further sleep study? A case report.World journal of cardiology · 2015Article
- Sleep and its Relationship to Racial and Ethnic Disparities in Cardiovascular Disease.Current cardiovascular risk reports · 2013Article
- Obstructive sleep apnea, posttraumatic stress disorder, and health in immigrants.Psychosomatic medicine · 2012Article
- Article
- Perioperative complications in patients with sleep apnea following primary total shoulder arthroplasty: An analysis of 33,366 patients.Journal of orthopaedicsArticle
- Sleep Disorders and Cardio-Renal Disease: Implications for Minority Populations.Epidemiology (Sunnyvale, Calif.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
Cardiovascular diseases are the leading cause of death among adults in developed countries. An increase in prevalent cardiovascular risk factors (e.g., obesity, hypertension and diabetes) has led to a concerted effort to raise awareness of the need to use evidence-based strategies to help patients at risk of developing cardiovascular disease and to reduce their likelihood of suffering a stroke. Sleep apnea has emerged as an important risk factor for the development of cardiovascular disease. Epidemiologic and clinical evidence has prompted the American Heart Association to issue a scientific statement describing the need to recognize sleep apnea as an important target for therapy in reducing cardiovascular disease risks. This article examines evidence supporting associations of sleep apnea with cardiovascular disease and considers evidence suggesting cardiovascular risk reductions through sleep apnea treatment. Perspectives on emerging therapeutic approaches and promising areas of clinical and experimental research are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.